STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $250,783 | -16.0% | 23,592 | -34.2% | 0.03% | -15.0% |
| Q1 2023 | $298,514 | -20.1% | 35,836 | -11.4% | 0.04% | -33.3% |
| Q4 2022 | $373,464 | +86.7% | 40,462 | +159.2% | 0.06% | +100.0% |
| Q3 2022 | $200,000 | -36.1% | 15,611 | -34.0% | 0.03% | +7.1% |
| Q2 2022 | $313,000 | -63.6% | 23,670 | -7.4% | 0.03% | -50.9% |
| Q2 2021 | $860,000 | +232.0% | 25,554 | +283.9% | 0.06% | +200.0% |
| Q1 2021 | $259,000 | – | 6,657 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |